Additionally, four novel potential genetic biomarkers for ALS have been identified in human bone marrow mesenchymal stem cells derived from patients: TAR DNA-binding protein 43 (TDP-43), secretory leukocyte protease inhibitor, CyFIP2, and RbBP9. Here, TARDBP is linked to amyotrophic lateral sclerosis.